Gates Foundation Strategic Investment Fund Logo
>
Share this page:

Press Release: Bill & Melinda Gates Foundation has agreed to join series B financing

Sera Prognostics

February 4, 2015

Sera Prognostics, Inc., a women’s healthcare company, today announced that the Bill & Melinda Gates Foundation has agreed to join the Company’s Series B financing, which will bring the total transaction to $25 million. The additional funding will help Sera expand the reach of its proteomic technology to develop new tests designed to predict the risk of preterm birth for women in developing countries around the world.

Read the full text here.